(Q30309230)

16 June 2017

1 reference

title

Viral respiratory infection therapy: historical perspectives and current trials (English)

1 reference

16 June 2017

Jack M Gwaltney

1

1 reference

16 June 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

American Journal of Medicine

16 June 2017

published in

1 reference

16 June 2017

volume

112 Suppl 6A

1 reference

16 June 2017

page(s)

33S-41S

1 reference

Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991.

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Efficacy of brompheniramine maleate for the treatment of rhinovirus colds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Effectiveness of clemastine fumarate for treatment of rhinorrhea and sneezing associated with the common cold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Variant effect of first- and second-generation antihistamines as clues to their mechanism of action on the sneeze reflex in the common cold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Acute community-acquired sinusitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Intranasal Interferon 2 for Prevention of Rhinovirus Infection and Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Combined antiviral and antimediator treatment of rhinovirus colds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Combined antiviral-antimediator treatment for the common cold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

Incubation periods of experimental rhinovirus infection and illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2801%2901062-2

10.1016/S0002-9343(01)01062-2

7 January 2021

Identifiers

DOI

1 reference

16 June 2017

1 reference